Human Papillomavirus Vaccine Market Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2025

Mar 2018| TMR327A| Transparency

Report Highlights

Human Papillomavirus Vaccine Market: Overview

This report on the global human papillomavirus vaccine market analyzes the current and future scenario of the global market. Rise in private and public funding for human papillomavirus vaccine, increase in government initiatives to prevent cervical cancer caused by human papillomavirus, growth in prevalence of various cancers caused by human papillomavirus are expected to drive the market during the forecast period.

The global human papillomavirus vaccine market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments.  It also provides information and data analysis of the global market with respect to segments based on valance, indication, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints, opportunities, and trends have been provided in the market overview section.  Additionally, the section comprises pipeline analysis to help understand the scope in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus providing a thorough analysis of the overall competitive scenario in the global human papillomavirus vaccine market.

In terms of valence, the market has been divided into Bivalent and Quadrivalent – nonavalent. Quadrivalent, and nonavalent segment is projected to lead the market and is expected to continue its dominance during the forecast period followed by bivalent segment. Launch of new multivalent human papillomavirus and increase in incidences of cervical cancer are likely to propel the segment. Based on indication type, cervical cancer dominated the market, in terms of revenue generated, in 2016 and is anticipated to continue its dominance during the forecast period. Anal cancer was the second largest segment in 2016 and it is likely to continue this trend from 2017 to 2025. In terms of distribution channel, government entities held a dominant share of the market. However, it is anticipated to lose market share during the forecast period owing to public and private alliances such as GAVI that are focused on vaccinating people in developing countries.

Geographically, the global human papillomavirus vaccine market has been categorized into major regions and key countries in the respective regions: North America (the US  and Canada), Europe (Germany, France, Italy, Spain, the UK, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa).  

The report also profiles major players operating in the global human papillomavirus vaccine market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments.  Major players profiled in this report include Merck & Co., Inc., GlaxoSmithKline plc. Sanofi, Johnson & Johnson, AstraZeneca, and Serum Institute of India Pvt. Ltd.

The global human papillomavirus vaccine market has been segmented as below:

Global Human Papillomavirus Vaccine Market, by Valence

Bivalent
Quadrivalent and Nonavalent

Global Human Papillomavirus Vaccine Market, by Indication

Cervical Cancer
Anal Cancer
Vaginal Cancer
Penile Cancer
Vulvar Cancer
Oropharyngeal Cancer
Genital Warts
Others

Global Human Papillomavirus Vaccine Market, by Distribution Channel

Physicians
Wholesalers
Physician Distributors
Government Entities
Public and Private Alliances

Global Human Papillomavirus Vaccine Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
UK
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Opportunity Map, by Valence 2016
  • Table 2 : Opportunity Map, by Indication 2016
  • Table 3 : Opportunity Map, by Distribution Channel 2016
  • Table 4 : Pipeline Analysis
  • Table 5 : Global Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Valence, 2015–2025
  • Table 6 : Global Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 7 : Global Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 8 : Global Human Papillomavirus Vaccines Market (US$ Mn) Forecast, by Region, 2015–2025
  • Table 9 : North America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 10 : North America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 11 : North America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 12 : North America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 13 : Europe Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 14 : Europe Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 15 : Europe Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 16 : Europe Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 17 : Asia Pacific Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 18 : Asia Pacific Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 19 : Asia Pacific Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 20 : Asia Pacific Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 21 : Latin America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 22 : Latin America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 23 : Latin America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 24 : Latin America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 25 : Middle East & Africa Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 26 : Middle East & Africa Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 27 : Middle East & Africa Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 28 : Middle East & Africa Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 29 : Human Papillomavirus (HPV) Vaccine Sales Analysis, 2014 – 2016
  • Figure 1 : Global Human Papillomavirus Vaccines Market, by Valence, Market Size (US$ Mn), 2016 (A)
  • Figure 2 : Global Human Papillomavirus Vaccines Market Revenue (%), by Indication, 2016 (A)
  • Figure 3 : By Valence Revenue (%), 2016
  • Figure 4 : By Indication Opportunity Map, 2016
  • Figure 5 : Vaccine Type Opportunity Map, 2016
  • Figure 6 : Global Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 7 : Market Value Share, by Valence (2016)
  • Figure 8 : Market Value Share, by Indication (2016)
  • Figure 9 : Market Value Share, by Distribution Channel (2016)
  • Figure 10 : Market Value Share, by Region (2016)
  • Figure 11 : Global Human Papillomavirus Vaccines Market Value Share, by Valence, 2016 and 2025
  • Figure 12 : Global Human Papillomavirus Vaccines Market Attractiveness, by Valence, 2017–2025
  • Figure 13 : Global Human Papillomavirus Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Bivalent, 2015–2025
  • Figure 14 : Global Human Papillomavirus Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Quadrivalent, and Nonavalent, 2015–2025
  • Figure 15 : Global Human Papillomavirus Vaccines Vaccines Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 16 : Global Cervical Cancer Market Revenue, US$ Mn, 2017–2025
  • Figure 17 : Global Anal Cancer Market Revenue, US$ Mn, 2017–2025
  • Figure 18 : Global Vaginal Cancer Market Revenue, US$ Mn, 2017–2025
  • Figure 19 : Global Penile Cancer Market Revenue, US$ Mn, 2017–2025
  • Figure 20 : Global Vulvar Cancers Market Revenue, US$ Mn, 2017–2025
  • Figure 21 : Global Oropharyngeal Cancer Market Revenue, US$ Mn, 2017–2025
  • Figure 22 : Global Genital Warts Market Revenue, US$ Mn, 2017–2025
  • Figure 23 : Global Others Market Revenue, US$ Mn, 2017–2025
  • Figure 24 : Global Human Papillomavirus Vaccines Market Attractiveness Analysis, by Indication
  • Figure 25 : Global Human Papillomavirus Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 26 : Global Human Papillomavirus Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 27 : Global Human Papillomavirus Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wholesalers Vaccines, 2015–2025
  • Figure 28 : Global Human Papillomavirus Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physicians Vaccines, 2015–2025
  • Figure 29 : Global Human Papillomavirus Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Government Entities Vaccine, 2015–2025
  • Figure 30 : Global Human Papillomavirus Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician Distributors Vaccine, 2015–2025
  • Figure 31 : Global Human Papillomavirus Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Vaccines, 2015–2025
  • Figure 32 : Global Human Papillomavirus Vaccines Market Analysis by Region, 2016 and 2025
  • Figure 33 : Global Human Papillomavirus Vaccines Market Attractiveness Analysis, by Region
  • Figure 34 : North America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 35 : North America Human Papillomavirus Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 36 : North America Human Papillomavirus Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 37 : North America Human Papillomavirus Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 38 : North America Human Papillomavirus Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 39 : highlights market value share of the HPV vaccines market in Europe, by indication, for 2016 and 2025.
  • Figure 39 : North America Human Papillomavirus Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 40 : North America Human Papillomavirus Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 41 : North America Human Papillomavirus Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 42 : North America Human Papillomavirus Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 43 : Europe Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 44 : Europe Human Papillomavirus Vaccines Market Value Share, by Country, 2016 and 2025
  • Figure 45 : Europe Human Papillomavirus Vaccines Market Attractiveness, by Country, 2017–2025
  • Figure 46 : Europe Human Papillomavirus Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 47 : Europe Human Papillomavirus Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 48 : Europe Human Papillomavirus Vaccines Market Value Share, by Indication, 2015 and 2025
  • Figure 49 : Europe Human Papillomavirus Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 50 : Europe Human Papillomavirus Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 51 : Europe Human Papillomavirus Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 52 : Asia Pacific Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 53 : Asia Pacific Human Papillomavirus Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 54 : Asia Pacific Human Papillomavirus Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 55 : Asia Pacific Human Papillomavirus Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 56 : Asia Pacific Human Papillomavirus Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 57 : Asia Pacific Human Papillomavirus Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 58 : Asia Pacific Human Papillomavirus Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 59 : Asia Pacific Human Papillomavirus Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 60 : Asia Pacific Human Papillomavirus Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 61 : Latin America Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 62 : Latin America Human Papillomavirus Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 63 : Latin America Human Papillomavirus Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 64 : Latin America Human Papillomavirus Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 65 : Latin America Human Papillomavirus Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 66 : Latin America Human Papillomavirus Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 67 : Latin America Human Papillomavirus Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 68 : Latin America Human Papillomavirus Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 69 : Latin America Human Papillomavirus Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 70 : Middle East & Africa Human Papillomavirus Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 71 : Middle East & Africa Human Papillomavirus Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 72 : Middle East & Africa Human Papillomavirus Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 73 : Middle East & Africa Human Papillomavirus Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 74 : Middle East & Africa Human Papillomavirus Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 75 : Middle East & Africa Human Papillomavirus Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 76 : Middle East & Africa Human Papillomavirus Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 77 : Middle East & Africa Human Papillomavirus Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 78 : Middle East & Africa Human Papillomavirus Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 79 : Human Papillomavirus (HPV) Vaccine Market Share, by Company, 2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us